2008•Zhonghua zhongyiyao xuekanRequires access

Toxicologic Study on Qishen Fukang Capsules

Shi Feng-qing

Open publisher page 0 citations

Abstract

Objective:To observe the acute toxicity Qishen Fukang Capsule in mice and its long-period toxicity in rats,so evaluated the safety dosage window in clinical application.Methods:The maximal tolerance dosage was tested by gastric perf usion of single oral dose of Qishen Fukang Capsule.Three groups of rats(in high,moderate and low dosage of Qishen Fukang Capsule)were administered with repeated gastric perf usion of Qishen Fukang Capsule for 26 weeks.Body weight,hematological and hema to2 biochemical parameters,coefficient and histomorp hological figure oforgans were examined in 13,26 weeks and 4 weeks after t he cessation of Qishen Fukang Capsule.Results:The oral maximal tolerance dose of Qishenfukang Capsule in mice was more than 39g/kg.There was no significant difference between the testgroups and the control in all tested parameters.Conclusion:The Qishen Fukang Capsule have no obviously toxicity,so suggest that Qishenfukang Capsule is safe for clinical application.

About this research paper

What this paper is about

Objective:To observe the acute toxicity Qishen Fukang Capsule in mice and its long-period toxicity in rats,so evaluated the safety dosage window in clinical application.Methods:The maximal tolerance dosage was tested by gastric perf usion of single oral dose of Qishen Fukang Capsule.Three groups of rats(in high,moderate and low dosage of Qishen Fukang Capsule)were administered with repeated gastric perf usion of Qishen Fukang Capsule for 26 weeks.Body weight,hematological and hema to2 biochemical parameters,coefficient and histomorp hological figure oforgans were examined in 13,26 weeks and 4 weeks after t he cessation of Qishen Fukang Capsule.Results:The oral maximal tolerance dose of Qishenfukang Capsule in mice was more than 39g/kg.There was no significant difference between the testgroups and the control in all tested parameters.Conclusion:The Qishen Fukang Capsule have no obviously toxicity,so suggest that Qishenfukang Capsule is safe for clinical application.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To observe the acute toxicity Qishen Fukang Capsule in mice and its long-period toxicity in rats,so evaluated the safety dosage window in clinical application.Methods:The maximal tolerance dosage was tested by gastric perf usion of single oral dose of Qishen Fukang Capsule.Three groups of rats(in high,moderate and low dosage of Qishen Fukang Capsule)were administered with repeated gastric perf usion of Qishen Fukang Capsule for 26 weeks.Body weight,hematological and hema to2 biochemical parameters,coefficient and histomorp hological figure oforgans were examined in 13,26 weeks and 4 weeks after t he cessation of Qishen Fukang Capsule.Results:The oral maximal tolerance dose of Qishenfukang Capsule in mice was more than 39g/kg.There was no significant difference between the testgroups and the control in all tested parameters.Conclusion:The Qishen Fukang Capsule have no obviously toxicity,so suggest that Qishenfukang Capsule is safe for clinical application.

Key concepts: Capsule, Medicine, Body weight, Acute toxicity, Toxicity, Anesthesia, Internal medicine, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Toxicologic Study on Qishen Fukang Capsules — Research Paper | ScholarLens